HGF and Miyoshi myopathy: Moreover, MPO250 influences the secretory profile of MM endothelial cell, and inhibits in vitro and in vivo angiogenic activities of MM endothelial cells at higher extent than anti-VEGF or anti-HGF neutralizing monoclonal antibodies.